Literature DB >> 24464449

Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice.

L Shi1, M Bi, R Yang, J Zhou, S Zhao, C Fan, Z Shan, Y Li, W Teng.   

Abstract

INTRODUCTION: The ability of B cells to negatively regulate cellular immune responses and inflammation has been described. The regulatory B (Breg) cells with the unique CD1d(hi)CD5(+)CD19(+) phenotype and the capacity to produce IL-10 are potent negative regulators of inflammation and autoimmunity in several in vivo mouse models of autoimmune disease. AIM: To investigate whether Breg cell deficiency participates in autoimmune thyroiditis (AIT) in an animal model.
MATERIALS AND METHODS: Non-obese diabetic (NOD).H-2(h4) mice at 4 weeks of age were randomly divided into control and iodine-treated groups; the iodine-treated group received sterile water containing 0.005 % NaI for 10 or 20 weeks. The percentage of CD1d(hi)CD5(+)CD19(+) Bregs, CD4(+)CD25(+)FoxP3(+) regulatory T cells (Treg) and CD4(+)IL17(+) T helper 17 cells (Th17) in splenic mononuclear cells was detected by multicolor flow cytometry. The expression of IL-10 mRNA and TGF-β mRNA in splenocytes was measured by real-time RT-PCR.
RESULTS: NOD.H-2(h4) mice spontaneously develop anti-thyroglobulin autoantibodies and intrathyroidal lymphocyte infiltration when supplied with iodine in drinking water. Mice with AIT had a decreased CD1d(hi)CD5(+)CD19(+) Breg subset and reduced IL-10 mRNA expression in splenocytes compared with controls (p < 0.05) and maintained relatively low levels during the development of thyroiditis. The proportion of Breg cells was negatively correlated with the proportion of Th17 cells, but positively correlated with CD4(+)CD25(+)FoxP3(+) Treg cells in splenocytes (All p < 0.05).
CONCLUSIONS: The defective expression of Breg cells combined with impaired Treg cells and enhanced Th17 cells might play an important role in the development of iodine-induced AIT in NOD.H-2(h4) mice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24464449     DOI: 10.1007/s40618-013-0013-1

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice.

Authors:  H Braley-Mullen; G C Sharp; B Medling; H Tang
Journal:  J Autoimmun       Date:  1999-05       Impact factor: 7.094

2.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

Review 3.  B lymphocytes: how they develop and function.

Authors:  Tucker W LeBien; Thomas F Tedder
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NOD mice.

Authors:  P R Hutchings; S Verma; J M Phillips; S Z Harach; S Howlett; A Cooke
Journal:  Cell Immunol       Date:  1999-03-15       Impact factor: 4.868

6.  Dynamic changes of CD4+CD25 + regulatory T cells in NOD.H-2h4 mice with iodine-induced autoimmune thyroiditis.

Authors:  Haibo Xue; Weiwei Wang; Zhongyan Shan; Yuanbin Li; Yushu Li; Xiaochun Teng; Yun Gao; Chenling Fan; Weiping Teng
Journal:  Biol Trace Elem Res       Date:  2010-09-07       Impact factor: 3.738

7.  Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner.

Authors:  Shabbir Hussain; Terry L Delovitch
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

8.  Regulatory B cells in autoimmune diseases: how do they work?

Authors:  Sébastien Lemoine; Ahsen Morva; Pierre Youinou; Christophe Jamin
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

9.  Prevention of arthritis by interleukin 10-producing B cells.

Authors:  Claudia Mauri; David Gray; Naseem Mushtaq; Marco Londei
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

Review 10.  Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.

Authors:  M C Dal Canto; R W Melvold; B S Kim; S D Miller
Journal:  Microsc Res Tech       Date:  1995-10-15       Impact factor: 2.769

View more
  8 in total

1.  Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.

Authors:  R M Ruggeri; M Cristani; T M Vicchio; A Alibrandi; S Giovinazzo; A Saija; A Campennì; F Trimarchi; S Gangemi
Journal:  J Endocrinol Invest       Date:  2018-05-23       Impact factor: 4.256

Review 2.  T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity.

Authors:  Roberto González-Amaro; Mónica Marazuela
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

3.  Iodine, thyroid autoimmunity and cancer.

Authors:  Emilio Fiore; Francesco Latrofa; Paolo Vitti
Journal:  Eur Thyroid J       Date:  2015-03-03

4.  The possible role of CD4⁺CD25(high)Foxp3⁺/CD4⁺IL-17A⁺ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis.

Authors:  Haibo Xue; Xiurong Yu; Lei Ma; Shoujun Song; Yuanbin Li; Li Zhang; Tingting Yang; Huan Liu
Journal:  Endocrine       Date:  2015-03-13       Impact factor: 3.633

5.  Effects of Selenium Supplement on B Lymphocyte Activity in Experimental Autoimmune Thyroiditis Rats.

Authors:  Yang Li; Xinhe Zuo; Chuan Hua; Yong Zhao; Xun Pei; Man Tian
Journal:  Int J Endocrinol       Date:  2021-08-10       Impact factor: 3.257

6.  Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.

Authors:  Rajni Sharma; Giulia Di Dalmazi; Patrizio Caturegli
Journal:  Thyroid       Date:  2016-07-22       Impact factor: 6.568

Review 7.  Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response.

Authors:  Ervin Ç Mingomataj; Alketa H Bakiri
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

8.  Increased Circulating Th17 but Decreased CD4+Foxp3+ Treg and CD19+CD1dhiCD5+ Breg Subsets in New-Onset Graves' Disease.

Authors:  Jing Qin; Jin Zhou; Chenling Fan; Na Zhao; Yongping Liu; Shuo Wang; Xuejiao Cui; Mingshi Huang; Haixia Guan; Yushu Li; Zhongyan Shan; Weiping Teng
Journal:  Biomed Res Int       Date:  2017-11-13       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.